Patents-Review.com
🔗 Permalink
Assignee profile:

RADIUS PHARMACEUTICALS, INC.

City:

Boston, Massachusetts

Country:

United States

Published Applications:

21

Last publication date:

2024-09-19

Patent Grants:

16

Last grant date:

2025-12-16

Top Inventors for applications by RADIUS PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to RADIUS PHARMACEUTICALS, INC.:

Recent patent applications by RADIUS PHARMACEUTICALS, INC.

RADIUS PHARMACEUTICALS, INC. based in Boston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-09-19 ✅ Patent 12,497,386 granted on 2025-12-16
US20240308986A1
Chemistry; metallurgy

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

 #2 | 2023-11-23 ✅ Patent 12,398,094 granted on 2025-08-26
US20230373904A1
Chemistry; metallurgy

POLYMORPHIC FORMS OF RAD1901-2HCL

 #3 | 2022-10-27 ✅ Patent 12,582,617 granted on 2026-03-24
US20220339126A1
Human necessities

METHODS FOR TREATING CANCER

 #4 | 2022-10-20 ✅ Patent 12,018,019 granted on 2024-06-25
US20220332704A1
Chemistry; metallurgy

Estrogen receptor-modulating compounds

 #5 | 2022-09-08 ✅ Patent 12,428,424 granted on 2025-09-30
US20220281875A1
Chemistry; metallurgy

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

 #6 | 2022-09-08
US20220280446A1
Human necessities

STABLE CANNABINOID FORMULATIONS

 #7 | 2022-06-16
US20220184215A1
Human necessities

STABLE CANNABINOID FORMULATIONS

 #8 | 2022-05-26 ✅ Patent 12,441,745 granted on 2025-10-14
US20220162233A1
Chemistry; metallurgy

PROCESSES AND COMPOUNDS

 #9 | 2022-04-28
US20220125932A1
Human necessities

STABLE CANNABINOID FORMULATIONS

 #10 | 2022-04-14 ✅ Patent 11,857,518 granted on 2024-01-02
US20220110890A1
Human necessities

Methods for treating cancer

 #11 | 2022-02-24
US20220054450A1
Human necessities

STABLE CANNABINOID FORMULATIONS

 #12 | 2022-02-17 ✅ Patent 11,708,318 granted on 2023-07-25
US20220048848A1
Chemistry; metallurgy

Polymorphic forms of RAD1901-2HCL

 #13 | 2021-10-28
US20210330797A1
Human necessities

STABLE CANNABINOID FORMULATIONS

 #14 | 2021-09-02 ✅ Patent 11,643,385 granted on 2023-05-09
US20210269389A1
Chemistry; metallurgy

Polymorphic forms of RAD1901-2HCl

 #15 | 2020-11-26 ✅ Patent 11,819,480 granted on 2023-11-21
US20200368183A1
Human necessities

Methods for treating cancer

 #16 | 2020-11-19 ✅ Patent 11,148,996 granted on 2021-10-19
US20200361853A1
Chemistry; metallurgy

Polymorphic forms of RAD1901-2HCL

 #17 | 2020-11-05 ✅ Patent 11,384,068 granted on 2022-07-12
US20200347032A1
Chemistry; metallurgy

Estrogen receptor-modulating compounds

 #18 | 2020-02-06 ✅ Patent 11,413,258 granted on 2022-08-16
US20200038343A1
Human necessities

Methods for treating cancer

 #19 | 2018-02-01 ✅ Patent 11,911,361 granted on 2024-02-27
US20180028489A1
Human necessities

Stable cannabinoid formulations

 #20 | 2015-12-03 ✅ Patent 11,224,660 granted on 2022-01-18
US20150343071A1
Human necessities

Stable cannabinoid formulations

 #21 | 2015-12-03 ✅ Patent 11,331,279 granted on 2022-05-17
US20150342902A1
Human necessities

Stable cannabinoid formulations

Also check out RADIUS PHARMACEUTICALS, INC.'s (Boston, United States) applicant profile with 23 patent applications submitted.

AssigneeID:

316535 ⎘